Article
The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Cancer letters - 10 Jul 2016
Kaur Harpreet, Ali Sabeen Zulfiqar, Huey Lauren, Hütt-Cabezas Marianne, Taylor Isabella, Mao Xing-Gang, Weingart Melanie, Chu Qian, Rodriguez Fausto J, Eberhart Charles G, Raabe Eric H
Abstract excerpt
Glioblastoma (GBM) contains a population of stem-like cells that promote tumor invasion and resistance to therapy. Identifying and targeting stem cell factors in GBM may lead to the development of more effective therapies. High Mobility Group AT-hook 2 (HMGA2) is a transcriptional modulator that mediates motility and self-renewal in normal and cancer stem cells. We identified increased expression of HMGA2 in the...
Topics
Join the communities discussing this publication.
